Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zhihao Gu, Yong Yan, Hequan Yao, Kejiang Lin & Xuanyi Li. (2022) Targeting the LPA1 signaling pathway for fibrosis therapy: a patent review (2010-present). Expert Opinion on Therapeutic Patents 32:10, pages 1097-1122.
Read now
Read now
Articles from other publishers (22)
Yun Huang, Chu-Ru Mao, Yijie Lou, Shuai Zhan, Zhe Chen, Wanjing Ding & Zhongjun Ma. (2023) Design, Synthesis, and Biological Evaluation of an Orally Bioavailable, Potent, and Selective ROCK2 Inhibitor for Psoriasis Treatment. Journal of Medicinal Chemistry 66:22, pages 15205-15229.
Crossref
Crossref
Mengqi Qin & Cynthia Yu-Wai-Man. (2023) Glaucoma: Novel antifibrotic therapeutics for the trabecular meshwork. European Journal of Pharmacology 954, pages 175882.
Crossref
Crossref
Giuseppina Nicolini, Silvana Balzan & Francesca Forini. (2023) Activated fibroblasts in cardiac and cancer fibrosis: An overview of analogies and new potential therapeutic options. Life Sciences 321, pages 121575.
Crossref
Crossref
Yang Chen & Daoquan Peng. (2023) New insights into the molecular mechanisms of SGLT2 inhibitors on ventricular remodeling. International Immunopharmacology 118, pages 110072.
Crossref
Crossref
Yuting Xie, Lin Yue, Yaojie Shi, Xingping Su, Cailing Gan, Hongyao Liu, Taixiong Xue & Tinghong Ye. (2023) Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future Perspectives. Journal of Medicinal Chemistry 66:7, pages 4342-4360.
Crossref
Crossref
Ning Xie, Cailan Xiao, Qiuai Shu, Bo Cheng, Ziwei Wang, Runxin Xue, Zhang Wen, Jinhai Wang, Haitao Shi, Daiming Fan, Na Liu & Feng Xu. (2023) Cell response to mechanical microenvironment cues via Rho signaling: From mechanobiology to mechanomedicine. Acta Biomaterialia 159, pages 1-20.
Crossref
Crossref
Tadeu L. Montagnoli, Daniela R. de Oliveira & Carlos A. Manssour Fraga. (2023) Therapeutic Perspectives on ROCK Inhibition for Cerebral Cavernous Malformations. Kinases and Phosphatases 1:1, pages 72-96.
Crossref
Crossref
Jianjian Shi & Lei Wei. (2022) Rho Kinases in Embryonic Development and Stem Cell Research. Archivum Immunologiae et Therapiae Experimentalis 70:1.
Crossref
Crossref
Yiming Wang, Yuqing Zhang & Dingguo Zhang. 2022. Frontiers in Cardiovascular Drug Discovery: Volume 6. Frontiers in Cardiovascular Drug Discovery: Volume 6
54
101
.
Brian Yu, Afaf E.G. Osman, Nikola Sladojevic, Nicole Prabhu, Haw-Chih Tai, Daiqing Chen, Gerardo Perla, Linus Park, Richard A. Larson & James K. Liao. (2022) Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular Toxicity. JACC: CardioOncology 4:3, pages 371-383.
Crossref
Crossref
Yuxuan Xiao, Roberto I Vazquez-Padron, Laisel Martinez, Harold A Singer, Daniel Woltmann & Loay H Salman. (2022) Role of platelet factor 4 in arteriovenous fistula maturation failure: What do we know so far?. The Journal of Vascular Access, pages 112972982210854.
Crossref
Crossref
Deniz Billur, Yusuf Olgar & Belma Turan. (2022) Intracellular Redistribution of Left Ventricular Connexin 43 Contributes to the Remodeling of Electrical Properties of the Heart in Insulin-resistant Elderly Rats. Journal of Histochemistry & Cytochemistry 70:6, pages 447-462.
Crossref
Crossref
Julian C. Bachmann, Simon J. Baumgart, Anna K. Uryga, Markus H. Bosteen, Giulia Borghetti, Michael Nyberg & Kate M. Herum. (2022) Fibrotic Signaling in Cardiac Fibroblasts and Vascular Smooth Muscle Cells: The Dual Roles of Fibrosis in HFpEF and CAD. Cells 11:10, pages 1657.
Crossref
Crossref
Fabian A Mendoza & Sergio A Jimenez. (2022) Serine/threonine kinase inhibition as antifibrotic therapy: transforming growth factor-β and Rho kinase inhibitors. Rheumatology 61:4, pages 1354-1365.
Crossref
Crossref
Hao Qian & Lijuan Chen. (2021) TRIM proteins in fibrosis. Biomedicine & Pharmacotherapy 144, pages 112340.
Crossref
Crossref
Yuxin Li, Haw‐Chih Tai, Nikola Sladojevic, Hyung‐Hwan Kim & James K. Liao. (2021) Vascular Stiffening Mediated by Rho‐Associated Coiled‐Coil Containing Kinase Isoforms. Journal of the American Heart Association 10:20.
Crossref
Crossref
Kevin W. Huang, Ian H. Wang, Ping Fu, Henry Krum, Leon A. Bach & Bing H. Wang. (2021) Insulin-like growth factor-1 directly affects cardiac cellular remodelling via distinct pathways. IJC Heart & Vasculature 36, pages 100852.
Crossref
Crossref
Dan Cristian Gheorghe, Andrei Ilie, Adelina-Gabriela Niculescu & Alexandru Mihai Grumezescu. (2021) Preventing Biofilm Formation and Development on Ear, Nose and Throat Medical Devices. Biomedicines 9:8, pages 1025.
Crossref
Crossref
Weijun Ou, Weimin Xu, Fangyuan Liu, Yuegui Guo, Zhenyu Huang, Tienan Feng, Chen-Ying Liu & Peng Du. (2021) Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease. eBioMedicine 69, pages 103452.
Crossref
Crossref
Tadeu L. Montagnoli, Jaqueline S. da Silva, Susumu Z. Sudo, Aimeé D. Santos, Gabriel F. Gomide, Mauro P. L. de Sá & Gisele Zapata-Sudo. (2021) ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension. Cells 10:7, pages 1648.
Crossref
Crossref
Corey Cutler. (2021) Treating Inflammation and Fibrosis in Chronic GVHD: Two Birds, One ROCK. Journal of Clinical Oncology 39:17, pages 1942-1945.
Crossref
Crossref
Maria Paz Ocaranza, Jorge E. Jalil, Rodrigo Altamirano, Ana de León, Jackeline Moya, Alejandra Lonis, Luigi Gabrielli, Paul Mac Nab, Samuel Córdova, Alejandro Paredes, Ismael Vergara, Alex Bittner, Karime Sabat & Karla Pastorini. (2021) Reverse Remodeling in Human Heart Failure after Cardiac Resynchronization Therapy Is Associated With Reduced RHO-Kinase Activation. Frontiers in Pharmacology 12.
Crossref
Crossref